The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Technology Regulatory News (FTV)

Share Price Information for Foresight Technology (FTV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 79.00
Bid: 77.50
Ask: 80.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.871%)
Open: 79.00
High: 79.00
Low: 79.00
Prev. Close: 79.00
FTV Live PriceLast checked at -
Foresight VCT is an Investment Trust

To provide private investors with attractive returns from a portfolio of investments in fast-growing unquoted companies based in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Foresight VCT plc - Publication of a supplementary prospectus

31 Mar 2020 14:34



Foresight VCT plc - Publication of a supplementary prospectus

FORESIGHT VCT PLC (Company)

Publication of Supplementary Prospectus

The Company issued a prospectus dated 28 January 2020 (Prospectus) relating to an offer for subscription to raise up to £20 million, with an over-allotment facility to raise up to a further £5 million (Offer). The Board announced utilisation of the over-allotment facility on 13 March 2020.

On 27 March 2020 the Company published an unaudited NAV per Share of 66.5p as at 27 March 2020 (a reduction of 14.1% from the unaudited NAV per share of 77.4p as at 31 December 2019, which was used for the prior allotment of Offer Shares) reflecting valuation reductions generally across the investments in the portfolio as a result of the market volatility arising from the impact of the Coronavirus (Covid-19) pandemic affecting all businesses including those in which the Company invests (Updated NAV Announcement).

The updated unaudited NAV per share referred to above represents a reduction of 13.3% from the unaudited NAV per share of 76.7p as at 30 September 2019, this being the latest unaudited published NAV per Share as at the date of the Prospectus. The updated NAV per share is a new significant factor in connection with the Offer and the Prospectus and, as a result, the Company has published a supplementary prospectus to the Prospectus (Supplementary Prospectus).

Investors who have already submitted application forms for new shares under the Offer have until 5.00 p.m. on 2 April 2020 by which they may withdraw such applications, should they wish to do so (as required under section 87Q(4)–(6) of the Financial Services and Markets Act 2000 (as amended). Further details of this right, including the deadline for withdrawal, is contained in the Supplementary Prospectus.

The updated NAV per share referred to above is also intended to be used for the purposes of calculating the number of shares to be issued to applicants under the Offer in respect of 2019/2020 and 2020/2021 tax year-end applications. The Board will, together with Foresight Group LLP, the Company’s manager, however, continue to keep this under review and will publish further updated NAVs per share (in particular for the purposes of an allotment of shares under the Offer if required).

A copy of the Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:

www.morningstar.co.uk/uk/nsm

Copies of this Supplementary Prospectus, together with the Prospectus, are available from the Manager’s website:

www.foresightgroup.eu

For further information please contact:

Company Secretary

Foresight Group LLP

Contact: Gary Fraser Tel: 0203 667 8100

Investor Relations

Foresight Group LLP

Contact: Ellie Kakoulli Tel: 0203 667 8181


Date   Source Headline
15th Apr 20246:20 pmGNWFinal Results
9th Apr 20244:02 pmGNWIssue of Equity
8th Apr 20247:33 pmGNWNet Asset Value(s)
28th Mar 20244:30 pmGNWTotal voting rights
21st Mar 20243:09 pmGNWIssue of Equity
11th Mar 20242:30 pmGNWPortfolio Update: Sale of portfolio company Specac International delivers 10.3x return for Foresight VCT PLC
29th Feb 20244:30 pmGNWTotal voting rights
22nd Feb 20244:13 pmGNWIssue of Equity
8th Feb 20243:35 pmGNWIssue of Equity
8th Feb 202412:28 pmGNWNet Asset Value(s)
31st Jan 20244:30 pmGNWTotal voting rights
26th Jan 20243:00 pmGNWOffer for Subscription - Update
11th Jan 20242:32 pmGNWIssue of Equity
29th Dec 20239:52 amGNWTotal voting rights
28th Dec 20235:47 pmGNWTransaction in Own Shares
22nd Dec 202312:25 pmGNWIssue of Equity
20th Dec 20237:00 amGNWOffer Update - Use of Over-Allotment Facility
14th Dec 20234:21 pmGNWDirector/PDMR Shareholding
14th Dec 20234:16 pmGNWIssue of Equity
14th Dec 20237:00 amGNWNet Asset Value(s)
30th Nov 20235:34 pmGNWNet Asset Value(s)
15th Nov 202312:55 pmGNWOffer and Prospectus
31st Oct 20234:00 pmGNWTotal voting rights
27th Oct 20235:02 pmGNWTransaction in Own Shares
26th Sep 20231:13 pmGNWUnaudited Half-Yearly Financial Report
11th Sep 202310:37 amGNWIntention to Fundraise
1st Sep 20237:58 amGNWTotal voting rights
18th Aug 20234:16 pmGNWDirector/PDMR Shareholding
18th Aug 20234:11 pmGNWIssue of Equity
31st Jul 20234:16 pmGNWTotal voting rights
31st Jul 20234:14 pmGNWTotal voting rights
27th Jul 20231:53 pmGNWDividend Declaration
30th Jun 20234:50 pmGNWTransaction in Own Shares
30th Jun 20233:14 pmGNWDirector/PDMR Shareholding
30th Jun 20233:12 pmGNWIssue of Equity
15th Jun 20233:34 pmGNWGM Statement
15th Jun 20233:29 pmGNWResult of AGM
31st May 20233:10 pmGNWNet Asset Value
31st May 20237:00 amGNWTotal voting rights
19th May 20235:29 pmGNWTransaction in Own Shares
18th May 20231:29 pmGNWPublication of a Circular
2nd May 20239:25 amGNWTotal voting rights - Correction
28th Apr 20234:00 pmGNWTotal voting rights
25th Apr 20235:06 pmGNWFinal Results
13th Apr 20233:07 pmGNWIssue of Equity
12th Apr 20239:56 amGNWCHANGE TO DIRECTOR INFORMATION
5th Apr 20233:54 pmGNWIssue of Equity
5th Apr 202311:13 amGNWNet Asset Value
3rd Apr 20238:00 amGNWPortfolio Update
30th Mar 20232:43 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.